Summary

The global biometrics as a service in the healthcare market is projected to reach USD 1.1 billion by 2028 from USD 0.4 billion in 2023, at a CAGR of 20.7% during the forecast period. The rapid expansion of telemedicine and remote patient monitoring, driven by the need for accessible healthcare services and the ongoing digital transformation of the industry, places an exceptional demand on secure and accurate patient identification. Biometrics, with their precision and reliability, emerge as indispensable tools in ensuring the integrity and safety of remote healthcare services. They not only safeguard sensitive patient data but also streamline authentication processes, enhancing the overall quality and trustworthiness of these services. As such, the integration of biometric solutions in telemedicine and remote patient monitoring is a pivotal driver in bolstering market growth and facilitating the widespread adoption of these innovative healthcare delivery methods. The absence of universally accepted biometric standards within the healthcare industry presents a significant challenge, potentially impeding the growth of the market.

"Software segment accounted for the largest share and is expected to grow at the highest rate during the forecast period."
Healthcare regulatory frameworks, notably HIPAA (Health Insurance Portability and Accountability Act), necessitate stringent authentication protocols and data security measures to safeguard sensitive patient information. In response to these imperative compliance demands, biometric software solutions have emerged as a pivotal asset for healthcare organizations. By seamlessly integrating biometric authentication methods into their operations, healthcare entities can effectively meet these compliance mandates, ensuring the confidentiality and integrity of patient data. This strategic alignment not only enhances regulatory adherence but also serves as a catalyst in propelling the continued growth of the healthcare biometrics market.

"The multimodal modality segment accounted for the largest share and is expected to grow at the highest rate during the forecast period."
Multimodal biometric solutions, characterized by utilizing multiple biometric modalities such as facial recognition, fingerprint scans, and iris recognition, are increasingly accessible to healthcare organizations of diverse sizes through the innovative Biometrics as a Service (BaaS) model. This cloud-based service delivery approach streamlines implementation and significantly reduces upfront capital expenditures. As a result, regardless of their scale, healthcare providers can harness the benefits of multimodal biometrics, bolstering their security and authentication measures, enhancing patient care, and simultaneously driving the growth trajectory of the healthcare biometrics market.

"Fingerprint solution segment accounted for the largest share of the global biometrics as a service in the healthcare market."
Fingerprint biometrics stand as a linchpin in the healthcare sector, assuring precise patient identification and mitigating the risk of duplicative medical records. This assurance not only elevates the quality of patient care but also streamlines administrative processes. Furthermore, fingerprint authentication is a robust means to verify patient consent in medical procedures and data sharing, thus engendering regulatory compliance and fortifying patient data privacy. The amalgamation of these attributes propels the sustained expansion of the healthcare biometrics market, as healthcare providers increasingly recognize the pivotal role of fingerprint biometrics in enhancing both patient care quality and data security.

"Medical record and data center security application segment accounted for the largest share and is expected to grow at the highest rate during the forecast period of the global biometrics as a service in the healthcare market."
Ongoing developments in biometric technology, exemplified by advancements in facial recognition and fingerprint scanning, have ushered in a new era of medical record and data center security marked by enhanced versatility and heightened levels of security. These technological strides not only expand the range of applications but also furnish more robust security measures, thereby positioning biometrics as a critical instrument for fortifying data center security infrastructure. In recognition of these advancements and their consequential impacts, the market for biometric solutions in medical record and data center security is poised for substantial growth, symbolizing the industry's commitment to adapt to evolving security requirements and to continually augment the safeguards surrounding critical data assets.

“Hospitals and clinics end-user segment held the largest market share growing at the highest CAGR during the forecast period of the biometrics as a service in the healthcare market.”
The strategic deployment of biometric authentication solutions has proven instrumental in the healthcare sector for the verification of insurance details, a measure that not only effectively curtails fraudulent activities but also significantly streamlines the complex billing processes inherent to the industry. By incorporating biometric measures into insurance verification procedures, healthcare organizations are distinctly positioned to bolster financial integrity while expediting billing procedures, exemplifying the industry's commitment to stringent financial oversight and operational efficiency. This strategic alignment underscores the instrumental role played by biometrics in advancing the healthcare biometrics market, emblematic of its pivotal contribution to optimizing financial processes within the sector.

“North America to Witness Significant Growth From 2023 to 2028.”
Biometrics as a service in the healthcare market has been segmented into four major regional segments: North America, Europe, Asia Pacific, and the Rest of the World. In 2022, the Asia Pacific region is anticipated to exhibit the highest compound annual growth rate (CAGR) during the forecast period. However, the North American market held the largest market share of the global market. The North American region benefits from a sophisticated and well-established healthcare infrastructure, which inherently facilitates the seamless adoption and integration of biometric solutions within existing healthcare systems. This advantage enables healthcare organizations to swiftly leverage the capabilities of biometric technologies, bolstering security, enhancing patient identification, and optimizing operational efficiency. Consequently, the North American market for healthcare biometrics experiences accelerated growth as these organizations harness the strengths of biometric solutions to address evolving healthcare challenges effectively and efficiently.

Breakdown of supply-side primary interviews: • By Company Type: Tier 1 – 40%, Tier 2 – 35%, and Tier 3 – 25% • By Designation: C-level – 25%, Director-level – 55%, and Others – 20% • By Region: North America - 40%, Europe – 25%, APAC – 20%, Latin America – 10%, Middle East & Africa – 5%

Some of the prominent players operating in the biometrics as a service in the healthcare market are NEC Corporation (Japan), Fujitsu Limited (Japan), Imprivata, Inc. (US), Suprema Inc. (South Korea), BIO-key International, Inc. (US), Thales (US), ASSA ABLOY (HID Global Corporation) (US), Cognitec Systems GmbH (Germany), Hitachi, Ltd. (Japan), Idex Biometrics ASA (Europe), Spectra Technovision(India) Pvt. Ltd. (India), Aware, Inc. (US), Aratek (US), Advent International, L.P. (US), NICE Ltd. (Israel), Voice Biometrics Group (US), Imageware (US)

Research Coverage
This report studies biometrics as a service in the healthcare market based on component, modality, solution type, end users, and regions. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting market growth. It analyzes the opportunities and challenges in the market and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micro markets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to four main regions and respective countries.
Reasons to Buy the Report
The report can help established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them garner a greater share. Firms purchasing the report could use one or a combination of the below-mentioned five strategies.

This report provides insights into the following pointers:
• Analysis of key drivers (growing need for patient identification and authentication, rising incidences of medical identity theft and data breaches, growing initiatives supporting biometrics adoption in healthcare), restraints (high costs associated with biometric systems, increased hygiene concerns and high risk of transmission of infectious diseases posed by touch-based biometric solutions), opportunities (increasing demand for advanced biometric solutions designed for authentication and identification applications, growing focus on availability of Biometric-as-a-Service solutions), and challenges (failure in detecting authorized and unauthorized users, complexities in implementing recognition technologies within existing healthcare systems) influencing the growth of healthcare biometrics/biometrics as a service in healthcare market.
• Product Development/Innovation: Detailed insights on upcoming technologies, research and development activities, and product launches in biometrics as a service in the healthcare market.
• Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various types of biometrics as a service across regions.
• Market Diversification: Exhaustive information about products, untapped regions, recent developments, and investments in biometrics as a service in the healthcare market.
• Competitive Assessment: In-depth assessment of market shares, strategies, products, distribution networks, and manufacturing capabilities of the leading players in biometrics as a service in the healthcare market.

ページTOPに戻る

Table of Contents

1 INTRODUCTION 26
1.1 STUDY OBJECTIVES 26
1.2 MARKET DEFINITION 26
1.2.1 INCLUSIONS AND EXCLUSIONS 26
1.3 MARKET SCOPE 27
1.3.1 MARKETS COVERED 27
FIGURE 1 BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET SEGMENTATION 27
1.3.2 REGIONS COVERED 27
1.3.3 YEARS CONSIDERED 28
1.3.4 CURRENCY CONSIDERED 28
1.4 STAKEHOLDERS 28
1.5 RECESSION IMPACT 29
2 RESEARCH METHODOLOGY 30
2.1 RESEARCH DATA 30
FIGURE 2 RESEARCH DESIGN 30
2.1.1 SECONDARY DATA 31
2.1.1.1 Key data from secondary sources 32
2.1.2 PRIMARY DATA 32
FIGURE 3 PRIMARY SOURCES 32
2.1.2.1 Key data from primary sources 33
2.1.2.2 Insights from primary experts 34
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION 34
2.2 MARKET SIZE ESTIMATION 35
2.2.1 APPROACH 1: BOTTOM-UP APPROACH 35
2.2.2 APPROACH 2: PRIMARY INTERVIEWS 35
2.2.3 APPROACH 3: TOP-DOWN APPROACH 35
FIGURE 5 TOP-DOWN APPROACH 35
FIGURE 6 CAGR PROJECTIONS FROM ANALYSIS OF MARKET DRIVERS, OPPORTUNITIES, AND CHALLENGES 36
FIGURE 7 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 37
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 38
FIGURE 8 DATA TRIANGULATION METHODOLOGY 38
2.4 MARKET SHARE ESTIMATION 39
2.5 ASSUMPTIONS AND RISK ASSESSMENT 39
TABLE 1 BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET: ASSUMPTIONS 39
TABLE 2 BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET: RISK ASSESSMENT 39
2.6 RESEARCH LIMITATIONS 40
2.7 RECESSION IMPACT ANALYSIS 40
3 EXECUTIVE SUMMARY 41
FIGURE 9 BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET, BY COMPONENT, 2023 VS. 2028 (USD MILLION) 41
FIGURE 10 BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET, BY MODALITY, 2023 VS. 2028 (USD MILLION) 42
FIGURE 11 BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET, BY SOLUTION TYPE, 2023 VS. 2028 (USD MILLION) 42
FIGURE 12 BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION) 43
FIGURE 13 BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET, BY END USER, 2023 VS. 2028 (USD MILLION) 43
FIGURE 14 BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET: GEOGRAPHICAL SNAPSHOT 44
4 PREMIUM INSIGHTS 45
4.1 BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET OVERVIEW 45
FIGURE 15 TECHNOLOGICAL ADVANCEMENT TO DRIVE MARKET GROWTH 45
4.2 BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 46
FIGURE 16 MIDDLE EAST & AFRICA TO REGISTER HIGHEST GROWTH OVER FORECAST PERIOD 46
4.3 REGIONAL MIX: BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET (2021–2028) 46
FIGURE 17 NORTH AMERICA TO RETAIN MARKET DOMINANCE THROUGHOUT STUDY PERIOD 46
4.4 BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET: DEVELOPED MARKETS VS. EMERGING ECONOMIES, 2023 VS. 2028 47
FIGURE 18 EMERGING ECONOMIES TO REGISTER HIGHER GROWTH OVER FORECAST PERIOD 47
5 MARKET OVERVIEW 48
5.1 INTRODUCTION 48
5.2 MARKET DYNAMICS 49
FIGURE 19 BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 49
5.2.1 DRIVERS 49
5.2.1.1 Growing need for patient identification and authentication 49
5.2.1.2 Rising incidences of medical identity theft and data breaches 50
TABLE 3 LARGEST HEALTHCARE DATA BREACHES IN AMERICA (JANUARY 2020–JULY 2023) 51
FIGURE 20 US: HEALTHCARE DATA BREACHES OF 500+ RECORDS (JANUARY 2009–JULY 2023) 52
5.2.1.3 Government initiatives supporting biometrics adoption in healthcare 52
5.2.2 RESTRAINTS 53
5.2.2.1 High costs associated with biometric systems 53
5.2.2.2 Concerns over hygiene and risk of transmitting infectious diseases 53
5.2.3 OPPORTUNITIES 54
5.2.3.1 Increasing demand for advanced biometric solutions designed for authentication and identification 54
TABLE 4 ADVANCEMENTS IN BIOMETRIC SYSTEMS 54
5.2.3.2 Growing focus on biometrics as a service solutions 54
5.2.4 CHALLENGES 55
5.2.4.1 Failure to detect authorized and unauthorized users 55
5.2.4.2 Complexities in implementing recognition technologies within existing healthcare systems 55
5.3 INDUSTRY TRENDS 56
5.3.1 MULTIMODAL BIOMETRICS 56
5.3.2 BIOMETRIC MOBILE APP SECURITY 56
5.4 TECHNOLOGY ANALYSIS 56
5.4.1 CLOUD-BASED BIOMETRIC SYSTEM 56
5.4.2 FINGER-VEIN RECOGNITION 57
5.4.3 3D FACE RECOGNITION 57
5.5 TARIFF AND REGULATORY LANDSCAPE 57
5.5.1 NORTH AMERICA 57
5.5.1.1 US 57
5.5.1.1.1 Health Insurance Portability and Accountability Act 57
5.5.1.1.2 Health Information Technology for Economic and Clinical Health Act 58
5.5.2 EUROPE 58
5.6 CASE STUDY ANALYSIS 59
5.6.1 USE CASE: ACCESS CONTROL AT BATES COUNTY MEMORIAL HOSPITAL IN EMPLOYEES’ HANDS 59
5.7 PORTER’S FIVE FORCES ANALYSIS 60
TABLE 5 BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET: PORTER’S FIVE FORCES ANALYSIS 60
5.7.1 THREAT OF NEW ENTRANTS 60
5.7.2 THREAT OF SUBSTITUTES 60
5.7.3 BARGAINING POWER OF SUPPLIERS 60
5.7.4 BARGAINING POWER OF BUYERS 60
5.7.5 INTENSITY OF COMPETITIVE RIVALRY 60
5.8 PRICING ANALYSIS 61
TABLE 6 BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET: PRICING BY SOLUTION TYPE 61
5.9 VALUE CHAIN ANALYSIS 61
FIGURE 21 BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET: VALUE CHAIN ANALYSIS (2022) 61
5.10 ECOSYSTEM MAPPING 62
FIGURE 22 ECOSYSTEM MAPPING: BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET 62
5.11 KEY CONFERENCES AND EVENTS, 2023–2024 62
TABLE 7 BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET: DETAILED LIST OF CONFERENCES AND EVENTS IN 2023–2024 62
5.12 PATENT ANALYSIS 63
5.12.1 PATENT PUBLICATION TRENDS FOR BIOMETRICS AS A SERVICE IN HEALTHCARE 63
FIGURE 23 PATENT PUBLICATION TRENDS (JANUARY 2012–JULY 2023) 63
5.12.2 JURISDICTION AND TOP APPLICANT ANALYSIS 64
FIGURE 24 TOP APPLICANTS AND OWNERS (COMPANIES/INSTITUTIONS) FOR BIOMETRICS AS A SERVICE IN HEALTHCARE PATENTS (JANUARY 2012–JULY 2023) 64
FIGURE 25 TOP APPLICANT COUNTRIES/REGIONS FOR BIOMETRICS AS A SERVICE IN HEALTHCARE PATENTS (JANUARY 2012–JULY 2023) 65
TABLE 8 LIST OF PATENTS/PATENT APPLICATIONS IN THE BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET, 2021–2023 65
5.13 KEY STAKEHOLDERS AND BUYING CRITERIA 67
5.13.1 KEY STAKEHOLDERS IN BUYING PROCESS 67
FIGURE 26 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS 67
TABLE 9 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS (%) 67
5.13.2 BUYING CRITERIA 68
FIGURE 27 KEY BUYING CRITERIA FOR COMPONENTS 68
TABLE 10 KEY BUYING CRITERIA FOR BIOMETRICS-AS-A-SERVICE COMPONENTS 68
5.14 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 69
FIGURE 28 REVENUE SHIFT IN BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET 69
6 BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET, BY COMPONENT 70
6.1 INTRODUCTION 71
TABLE 11 BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET, BY COMPONENT, 2021–2028 (USD MILLION) 71
6.2 SOFTWARE 72
6.2.1 SOFTWARE TO HOLD LARGEST MARKET SHARE 72
TABLE 12 BIOMETRICS SOFTWARE MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 72
6.3 SERVICES 73
6.3.1 CONTINUED DEMAND FOR SERVICES TO ENSURE MARKET GROWTH 73
TABLE 13 BIOMETRICS SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 73
7 BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET, BY MODALITY 74
7.1 INTRODUCTION 75
TABLE 14 BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET, BY MODALITY, 2021–2028 (USD MILLION) 75
7.2 MULTIMODAL 76
7.2.1 HIGHER ACCURACY AND BETTER PERFORMANCE TO DRIVE MARKET 76
TABLE 15 MULTIMODAL BIOMETRICS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 76
7.3 UNIMODAL 77
7.3.1 EASE OF IMPLEMENTATION TO SUPPORT ADOPTION 77
TABLE 16 UNIMODAL BIOMETRICS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 77
8 BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET, BY SOLUTION TYPE 78
8.1 INTRODUCTION 79
TABLE 17 BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET, BY SOLUTION TYPE, 2021–2028 (USD MILLION) 79
8.2 FINGERPRINT SCANNING 80
8.2.1 FINGERPRINT SCANNING TO HOLD LARGEST MARKET SHARE TILL 2028 80
TABLE 18 FINGERPRINT SCANNING FOR HEALTHCARE MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 80
8.3 FACIAL RECOGNITION 81
8.3.1 EASE OF USE, CONVENIENCE, AND PERFORMANCE IN DIFFERENT ENVIRONMENTS TO DRIVE DEMAND 81
TABLE 19 FACIAL RECOGNITION FOR HEALTHCARE MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 81
8.4 IRIS RECOGNITION 82
8.4.1 INCREASED ACCURACY OF IRIS RECOGNITION TO DRIVE THE MARKET 82
TABLE 20 IRIS RECOGNITION FOR HEALTHCARE MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 82
8.5 VOICE RECOGNITION 83
8.5.1 IMPLEMENTATION OF SPEECH RECOGNITION IN MEDICAL DEVICES TO DRIVE MARKET 83
TABLE 21 VOICE RECOGNITION FOR HEALTHCARE MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 83
8.6 PALM & VEIN RECOGNITION 84
8.6.1 DIFFICULTY IN DUPLICATING VEIN PATTERNS TO BOOST DEMAND 84
TABLE 22 PALM & VEIN RECOGNITION FOR HEALTHCARE MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 84
8.7 OTHER SOLUTIONS 85
TABLE 23 OTHER BIOMETRICS SOLUTIONS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 85
9 BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET, BY APPLICATION 86
9.1 INTRODUCTION 87
TABLE 24 BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 87
9.2 MEDICAL RECORD & DATA CENTER SECURITY 88
9.2.1 MEDICAL RECORD & DATA CENTER SECURITY TO HOLD LARGEST MARKET SHARE TILL 2028 88
TABLE 25 BIOMETRICS AS A SERVICE IN MEDICAL RECORD & DATA CENTER SECURITY MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 88
9.3 PATIENT IDENTIFICATION & TRACKING 89
9.3.1 NEED FOR ENHANCED DATA SECURITY AND PRIVACY TO DRIVE ADOPTION 89
TABLE 26 BIOMETRICS AS A SERVICE IN PATIENT IDENTIFICATION & TRACKING MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 89
9.4 CARE PROVIDER AUTHENTICATION 90
9.4.1 ENHANCED PATIENT SAFETY TO DRIVE THE MARKET 90
TABLE 27 BIOMETRICS AS A SERVICE IN CARE PROVIDER AUTHENTICATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 90
9.5 RPM 91
9.5.1 IMPROVED PATIENT OUTCOMES AND QUALITY OF CARE TO DRIVE DEMAND FOR RPM 91
TABLE 28 BIOMETRICS AS A SERVICE IN RPM MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 91
9.6 PHARMACY DISPENSING 92
9.6.1 NEED TO IMPROVE MEDICATION SAFETY TO BOOST MARKET GROWTH 92
TABLE 29 BIOMETRICS AS A SERVICE IN PHARMACY DISPENSING MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 92
9.7 OTHER APPLICATIONS 93
TABLE 30 BIOMETRICS AS A SERVICE IN OTHER HEALTHCARE APPLICATIONS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 93
10 BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET, BY END USER 94
10.1 INTRODUCTION 95
TABLE 31 BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET, BY END USER, 2021–2028 (USD MILLION) 95
10.2 HOSPITALS & CLINICS 95
10.2.1 HOSPITALS & CLINICS TO FORM LARGEST END-USER SEGMENT 95
TABLE 32 BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2021–2028 (USD MILLION) 96
10.3 LONG-TERM CARE CENTERS & HOME CARE SETTINGS 96
10.3.1 SUPPORT TO ENHANCE PATIENT CARE OUTCOMES TO ENSURE DEMAND FOR BIOMETRICS 96
TABLE 33 BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET FOR LONG-TERM CARE CENTERS & HOME CARE SETTINGS, BY COUNTRY, 2021–2028 (USD MILLION) 97
10.4 AMBULATORY SURGICAL CENTERS 97
10.4.1 RISING DEMAND FOR OUTPATIENT CARE TO FAVOR MARKET GROWTH 97
TABLE 34 BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET FOR AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2021–2028 (USD MILLION) 98
10.5 OTHER END USERS 99
TABLE 35 BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION) 99
11 BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET, BY REGION 100
11.1 INTRODUCTION 101
TABLE 36 BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET, BY REGION, 2021–2028 (USD MILLION) 101
11.2 NORTH AMERICA 101
FIGURE 29 NORTH AMERICA: BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET SNAPSHOT 102
TABLE 37 NORTH AMERICA: BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 102
TABLE 38 NORTH AMERICA: BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET, BY COMPONENT, 2021–2028 (USD MILLION) 103
TABLE 39 NORTH AMERICA: BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET, BY MODALITY, 2021–2028 (USD MILLION) 103
TABLE 40 NORTH AMERICA: BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET, BY SOLUTION TYPE, 2021–2028 (USD MILLION) 103
TABLE 41 NORTH AMERICA: BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 104
TABLE 42 NORTH AMERICA: BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET, BY END USER, 2021–2028 (USD MILLION) 104
11.2.1 US 104
11.2.1.1 US to dominate North American market 104
TABLE 43 US: BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET, BY COMPONENT, 2021–2028 (USD MILLION) 105
TABLE 44 US: BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET, BY MODALITY, 2021–2028 (USD MILLION) 105
TABLE 45 US: BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET, BY SOLUTION TYPE, 2021–2028 (USD MILLION) 105
TABLE 46 US: BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 106
TABLE 47 US: BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET, BY END USER, 2021–2028 (USD MILLION) 106
11.2.2 CANADA 106
11.2.2.1 Technological advancements, increasing adoption of EHRs to boost market growth 106
TABLE 48 CANADA: BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET, BY COMPONENT, 2021–2028 (USD MILLION) 107
TABLE 49 CANADA: BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET, BY MODALITY, 2021–2028 (USD MILLION) 107
TABLE 50 CANADA: BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET, BY SOLUTION TYPE, 2021–2028 (USD MILLION) 107
TABLE 51 CANADA: BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 108
TABLE 52 CANADA: BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET, BY END USER, 2021–2028 (USD MILLION) 108
11.3 EUROPE 108
FIGURE 30 EUROPE: BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET SNAPSHOT 109
TABLE 53 EUROPE: BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 110
TABLE 54 EUROPE: BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET, BY COMPONENT, 2021–2028 (USD MILLION) 110
TABLE 55 EUROPE: BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET, BY MODALITY, 2021–2028 (USD MILLION) 110
TABLE 56 EUROPE: BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET, BY SOLUTION TYPE, 2021–2028 (USD MILLION) 111
TABLE 57 EUROPE: BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 111
TABLE 58 EUROPE: BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET, BY END USER, 2021–2028 (USD MILLION) 112
11.3.1 GERMANY 112
11.3.1.1 Germany to dominate market in Europe 112
TABLE 59 GERMANY: BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET, BY COMPONENT, 2021–2028 (USD MILLION) 112
TABLE 60 GERMANY: BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET, BY MODALITY, 2021–2028 (USD MILLION) 113
TABLE 61 GERMANY: BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET, BY SOLUTION TYPE, 2021–2028 (USD MILLION) 113
TABLE 62 GERMANY: BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 114
TABLE 63 GERMANY: BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET, BY END USER, 2021–2028 (USD MILLION) 114
11.3.2 UK 114
11.3.2.1 Technological developments to support market growth 114
TABLE 64 UK: BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET, BY COMPONENT, 2021–2028 (USD MILLION) 115
TABLE 65 UK: BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET, BY MODALITY, 2021–2028 (USD MILLION) 115
TABLE 66 UK: BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET, BY SOLUTION TYPE, 2021–2028 (USD MILLION) 115
TABLE 67 UK: BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 116
TABLE 68 UK: BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET, BY END USER, 2021–2028 (USD MILLION) 116
11.3.3 FRANCE 116
11.3.3.1 Rising population, decreased mortality ratio, and growing adoption of digital healthcare to drive market 116
TABLE 69 FRANCE: BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET, BY COMPONENT, 2021–2028 (USD MILLION) 117
TABLE 70 FRANCE: BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET, BY MODALITY, 2021–2028 (USD MILLION) 117
TABLE 71 FRANCE: BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET, BY SOLUTION TYPE, 2021–2028 (USD MILLION) 118
TABLE 72 FRANCE: BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 118
TABLE 73 FRANCE: BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET, BY END USER, 2021–2028 (USD MILLION) 119
11.3.4 REST OF EUROPE 119
TABLE 74 REST OF EUROPE: BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET, BY COMPONENT, 2021–2028 (USD MILLION) 120
TABLE 75 REST OF EUROPE: BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET, BY MODALITY, 2021–2028 (USD MILLION) 120
TABLE 76 REST OF EUROPE: BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET, BY SOLUTION TYPE, 2021–2028 (USD MILLION) 120
TABLE 77 REST OF EUROPE: BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 121
TABLE 78 REST OF EUROPE: BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET, BY END USER, 2021–2028 (USD MILLION) 121
11.4 ASIA PACIFIC 121
TABLE 79 ASIA PACIFIC: BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 122
TABLE 80 ASIA PACIFIC: BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET, BY COMPONENT, 2021–2028 (USD MILLION) 122
TABLE 81 ASIA PACIFIC: BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET, BY MODALITY, 2021–2028 (USD MILLION) 123
TABLE 82 ASIA PACIFIC: BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET, BY SOLUTION TYPE, 2021–2028 (USD MILLION) 123
TABLE 83 ASIA PACIFIC: BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 124
TABLE 84 ASIA PACIFIC: BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET, BY END USER, 2021–2028 (USD MILLION) 124
11.4.1 CHINA 124
11.4.1.1 China to hold largest market share 124
TABLE 85 CHINA: BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET, BY COMPONENT, 2021–2028 (USD MILLION) 125
TABLE 86 CHINA: BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET, BY MODALITY, 2021–2028 (USD MILLION) 125
TABLE 87 CHINA: BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET, BY SOLUTION TYPE, 2021–2028 (USD MILLION) 125
TABLE 88 CHINA: BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 126
TABLE 89 CHINA: BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET, BY END USER, 2021–2028 (USD MILLION) 126
11.4.2 JAPAN 126
11.4.2.1 High geriatric population to favor healthcare technology adoption 126
TABLE 90 JAPAN: BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET, BY COMPONENT, 2021–2028 (USD MILLION) 127
TABLE 91 JAPAN: BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET, BY MODALITY, 2021–2028 (USD MILLION) 127
TABLE 92 JAPAN: BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET, BY SOLUTION TYPE, 2021–2028 (USD MILLION) 128
TABLE 93 JAPAN: BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 128
TABLE 94 JAPAN: BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET, BY END USER, 2021–2028 (USD MILLION) 129
11.4.3 INDIA 129
11.4.3.1 Growing adoption of digital healthcare to drive market 129
TABLE 95 INDIA: BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET, BY COMPONENT, 2021–2028 (USD MILLION) 129
TABLE 96 INDIA: BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET, BY MODALITY, 2021–2028 (USD MILLION) 130
TABLE 97 INDIA: BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET, BY SOLUTION TYPE, 2021–2028 (USD MILLION) 130
TABLE 98 INDIA: BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 131
TABLE 99 INDIA: BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET, BY END USER, 2021–2028 (USD MILLION) 131
11.4.4 REST OF ASIA PACIFIC 131
TABLE 100 REST OF ASIA PACIFIC: BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET, BY COMPONENT, 2021–2028 (USD MILLION) 132
TABLE 101 REST OF ASIA PACIFIC: BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET, BY MODALITY, 2021–2028 (USD MILLION) 132
TABLE 102 REST OF ASIA PACIFIC: BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET, BY SOLUTION TYPE, 2021–2028 (USD MILLION) 133
TABLE 103 REST OF ASIA PACIFIC: BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 133
TABLE 104 REST OF ASIA PACIFIC: BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET, BY END USER, 2021–2028 (USD MILLION) 134
11.5 LATIN AMERICA 134
11.5.1 EXTENSIVE USE OF INTERNET AND MOBILE-BASED APPLICATIONS TO SUPPORT ADOPTION OF BAAS IN HEALTHCARE 134
TABLE 105 LATIN AMERICA: BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET, BY COMPONENT, 2021–2028 (USD MILLION) 135
TABLE 106 LATIN AMERICA: BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET, BY MODALITY, 2021–2028 (USD MILLION) 135
TABLE 107 LATIN AMERICA: BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET, BY SOLUTION TYPE, 2021–2028 (USD MILLION) 135
TABLE 108 LATIN AMERICA: BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 136
TABLE 109 LATIN AMERICA: BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET, BY END USER, 2021–2028 (USD MILLION) 136
11.6 MIDDLE EAST & AFRICA 136
11.6.1 DEVELOPMENTS IN IT INFRASTRUCTURE TO SUPPORT ADOPTION 136
TABLE 110 MIDDLE EAST & AFRICA: BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET, BY COMPONENT, 2021–2028 (USD MILLION) 137
TABLE 111 MIDDLE EAST & AFRICA: BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET, BY MODALITY, 2021–2028 (USD MILLION) 137
TABLE 112 MIDDLE EAST & AFRICA: BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET, BY SOLUTION TYPE, 2021–2028 (USD MILLION) 137
TABLE 113 MIDDLE EAST & AFRICA: BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 138
TABLE 114 MIDDLE EAST & AFRICA: BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET, BY END USER, 2021–2028 (USD MILLION) 138
12 COMPETITIVE LANDSCAPE 139
12.1 OVERVIEW 139
FIGURE 31 OVERVIEW OF STRATEGIES ADOPTED BY MAJOR PLAYERS BETWEEN JANUARY 2020 AND AUGUST 2023 139
12.2 MARKET RANKING ANALYSIS 140
FIGURE 32 BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET RANKING ANALYSIS, BY PLAYER, 2022 140
12.3 REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS 141
FIGURE 33 BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET: REVENUE ANALYSIS OF KEY PLAYERS 141
12.4 COMPANY EVALUATION MATRIX FOR KEY PLAYERS (2022) 141
12.4.1 STARS 141
12.4.2 EMERGING LEADERS 141
12.4.3 PERVASIVE PLAYERS 142
12.4.4 PARTICIPANTS 142
FIGURE 34 BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET: COMPANY EVALUATION MATRIX FOR KEY PLAYERS (2022) 142
12.5 COMPANY EVALUATION MATRIX FOR STARTUPS/SMES (2022) 143
12.5.1 PROGRESSIVE COMPANIES 143
12.5.2 DYNAMIC COMPANIES 143
12.5.3 RESPONSIVE COMPANIES 143
12.5.4 STARTING BLOCKS 143
FIGURE 35 BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET: COMPANY EVALUATION MATRIX FOR STARTUPS/SMES (2022) 144
12.6 COMPETITIVE BENCHMARKING 145
TABLE 115 BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET: COMPANY FOOTPRINT ANALYSIS 145
TABLE 116 COMPANY COMPONENT FOOTPRINT (17 COMPANIES) 145
TABLE 117 COMPANY SOLUTION TYPE FOOTPRINT (17 COMPANIES) 146
TABLE 118 COMPANY REGIONAL FOOTPRINT (17 COMPANIES) 147
12.7 COMPETITIVE SCENARIO 148
12.7.1 PRODUCT/SERVICE LAUNCHES & APPROVALS 148
TABLE 119 PRODUCT/SERVICE LAUNCHES & APPROVALS, JANUARY 2020– JUNE 2023 148
12.7.2 DEALS 148
TABLE 120 DEALS, JANUARY 2020– MAY 2023 148
13 COMPANY PROFILES 150
13.1 KEY PLAYERS 150
(Business overview, Products & services offered, Recent developments, MnM view, Key strengths/Right to win, Strategic choices made, and Weaknesses & Competitive threats)*
13.1.1 THALES 150
TABLE 121 THALES: COMPANY OVERVIEW 150
FIGURE 36 THALES: COMPANY SNAPSHOT (2022) 151
13.1.2 IMPRIVATA, INC. (THOMA BRAVO) 153
TABLE 122 IMPRIVATA, INC.: COMPANY OVERVIEW 153
13.1.3 NEC CORPORATION 156
TABLE 123 NEC CORPORATION: COMPANY OVERVIEW 156
FIGURE 37 NEC CORPORATION: COMPANY SNAPSHOT (2022) 157
13.1.4 FUJITSU 159
TABLE 124 FUJITSU: COMPANY OVERVIEW 159
FIGURE 38 FUJITSU: COMPANY SNAPSHOT (2022) 160
13.1.5 BIO-KEY INTERNATIONAL, INC. 162
TABLE 125 BIO-KEY INTERNATIONAL, INC.: COMPANY OVERVIEW 162
FIGURE 39 BIO-KEY INTERNATIONAL, INC.: COMPANY SNAPSHOT (2022) 163
13.1.6 ARATEK 165
TABLE 126 ARATEK: COMPANY OVERVIEW 165
13.1.7 IDEX BIOMETRICS ASA 166
TABLE 127 IDEX BIOMETRICS ASA: COMPANY OVERVIEW 166
FIGURE 40 IDEX BIOMETRICS ASA: COMPANY SNAPSHOT (2022) 167
13.1.8 ASSA ABLOY (HID GLOBAL CORPORATION) 168
TABLE 128 ASSA ABLOY: COMPANY OVERVIEW 168
FIGURE 41 ASSA ABLOY: COMPANY SNAPSHOT (2022) 169
13.1.9 HITACHI, LTD. 170
TABLE 129 HITACHI, LTD.: COMPANY OVERVIEW 170
FIGURE 42 HITACHI, LTD.: COMPANY SNAPSHOT (2022) 171
13.1.10 IDEMIA (ADVENT INTERNATIONAL, L.P.) 173
TABLE 130 IDEMIA: COMPANY OVERVIEW 173
13.1.11 COGNITEC SYSTEMS GMBH 174
TABLE 131 COGNITEC SYSTEMS GMBH: COMPANY OVERVIEW 174
13.1.12 AWARE, INC. 175
TABLE 132 AWARE, INC.: COMPANY OVERVIEW 175
FIGURE 43 AWARE, INC.: COMPANY SNAPSHOT (2022) 176
13.1.13 SUPREMA INC. 178
TABLE 133 SUPREMA, INC.: COMPANY OVERVIEW 178
13.1.14 NICE LTD. 179
TABLE 134 NICE LTD.: COMPANY OVERVIEW 179
FIGURE 44 NICE LTD.: COMPANY SNAPSHOT (2022) 180
13.1.15 SPECTRA TECHNOVISION (INDIA) PVT. LTD. 182
TABLE 135 SPECTRA TECHNOVISION (INDIA) PVT. LTD.: COMPANY OVERVIEW 182
13.1.16 VOICE BIOMETRICS GROUP 183
TABLE 136 VOICE BIOMETRICS GROUP: COMPANY OVERVIEW 183
13.1.17 IMAGEWARE (TECH5) 184
TABLE 137 IMAGEWARE: COMPANY OVERVIEW 184
FIGURE 45 IMAGEWARE: COMPANY SNAPSHOT (2021) 184
13.2 OTHER PLAYERS 186
13.2.1 LEIDOS 186
13.2.2 RELX GROUP PLC (LEXISNEXIS RISK SOLUTIONS) 187
13.2.3 FACETEC, INC. 187
13.2.4 DAON, INC. 188
13.2.5 PRINCETON IDENTITY 188
13.2.6 INTEGRATED BIOMETRICS 189
13.2.7 REDROCK BIOMETRICS 190
13.2.8 RIGHTPATIENT 190
*Details on Business overview, Products & services offered, Recent developments, MnM view, Key strengths/Right to win, Strategic choices made, and Weaknesses & Competitive threats might not be captured in case of unlisted companies.
14 APPENDIX 191
14.1 DISCUSSION GUIDE 191
14.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 195
14.3 CUSTOMIZATION OPTIONS 197
14.4 RELATED REPORTS 197
14.5 AUTHOR DETAILS 198